| Primary |
| Atrial Fibrillation |
56.2% |
| Drug Use For Unknown Indication |
15.3% |
| Product Used For Unknown Indication |
10.3% |
| Arrhythmia |
6.4% |
| Atrial Flutter |
1.8% |
| Supraventricular Tachycardia |
1.4% |
| Heart Rate Irregular |
1.1% |
| Hypertension |
1.1% |
| Ventricular Arrhythmia |
1.1% |
| Anticoagulant Therapy |
0.7% |
| Atrial Tachycardia |
0.7% |
| Cardiovascular Disorder |
0.7% |
| Thrombosis Prophylaxis |
0.7% |
| Blood Pressure |
0.4% |
| Bronchitis |
0.4% |
| Cardiac Disorder |
0.4% |
| Cardioversion |
0.4% |
| Glaucoma |
0.4% |
| Gout |
0.4% |
| Heart Rate Increased |
0.4% |
|
| Tremor |
10.4% |
| Atrial Fibrillation |
9.4% |
| Drug Ineffective |
9.4% |
| Product Quality Issue |
9.4% |
| Rash |
5.7% |
| Death |
4.7% |
| Heart Rate Decreased |
4.7% |
| Malaise |
4.7% |
| Vomiting |
4.7% |
| Weight Increased |
4.7% |
| Hypotension |
3.8% |
| Neuropathy Peripheral |
3.8% |
| Palpitations |
3.8% |
| Pelvic Fracture |
3.8% |
| Adverse Event |
2.8% |
| Arrhythmia |
2.8% |
| Cardiac Disorder |
2.8% |
| Cerebrovascular Accident |
2.8% |
| Dysgeusia |
2.8% |
| Nausea |
2.8% |
|
| Secondary |
| Drug Use For Unknown Indication |
32.5% |
| Atrial Fibrillation |
19.2% |
| Hypertension |
8.9% |
| Cerebrovascular Accident |
3.9% |
| Diabetes Mellitus |
3.9% |
| Fibromyalgia |
3.9% |
| Hormone Replacement Therapy |
3.9% |
| Hypothyroidism |
3.9% |
| Muscle Spasms |
3.9% |
| Atrial Flutter |
3.0% |
| Cardiac Failure Congestive |
3.0% |
| Hypokalaemia |
3.0% |
| Arrhythmia |
2.5% |
| Product Used For Unknown Indication |
1.5% |
| Bronchiectasis |
1.0% |
| Cardiac Disorder |
0.5% |
| Fluid Retention |
0.5% |
| Parkinson's Disease |
0.5% |
| Rales |
0.5% |
|
| Skin Ulcer |
25.8% |
| Dyspnoea |
9.7% |
| Drug Ineffective |
6.5% |
| Productive Cough |
6.5% |
| Weight Increased |
6.5% |
| Blood Urine Present |
3.2% |
| Dizziness |
3.2% |
| Fatigue |
3.2% |
| Feeling Abnormal |
3.2% |
| Heart Rate Irregular |
3.2% |
| Myocardial Infarction |
3.2% |
| Nervousness |
3.2% |
| Overdose |
3.2% |
| Product Quality Issue |
3.2% |
| Spinal Fracture |
3.2% |
| Tachycardia |
3.2% |
| Therapeutic Response Decreased |
3.2% |
| Underdose |
3.2% |
| Ventricular Fibrillation |
3.2% |
|
| Concomitant |
| Atrial Fibrillation |
34.7% |
| Hypertension |
20.0% |
| Cardiac Disorder |
5.3% |
| Blood Cholesterol Increased |
4.2% |
| Arrhythmia |
3.2% |
| Drug Use For Unknown Indication |
3.2% |
| Hepatitis C |
3.2% |
| Pulmonary Arterial Hypertension |
3.2% |
| Afib |
2.1% |
| Anticoagulant Therapy |
2.1% |
| Cerebrovascular Accident Prophylaxis |
2.1% |
| Metastatic Malignant Melanoma |
2.1% |
| Mineral Supplementation |
2.1% |
| Osteoporosis |
2.1% |
| Product Used For Unknown Indication |
2.1% |
| Psoriasis |
2.1% |
| Rheumatoid Arthritis |
2.1% |
| Vitamin Supplementation |
2.1% |
| Arthralgia |
1.1% |
| Atrial Tachycardia |
1.1% |
|
| Dyspepsia |
13.6% |
| Atrial Fibrillation |
4.5% |
| Body Temperature Decreased |
4.5% |
| Constipation |
4.5% |
| Dizziness |
4.5% |
| Erythema |
4.5% |
| Faeces Discoloured |
4.5% |
| Feeling Abnormal |
4.5% |
| Haemorrhagic Anaemia |
4.5% |
| International Normalised Ratio |
4.5% |
| International Normalised Ratio Increased |
4.5% |
| Muscle Spasms |
4.5% |
| Nausea |
4.5% |
| Paranoia |
4.5% |
| Parosmia |
4.5% |
| Post Procedural Hypothyroidism |
4.5% |
| Product Quality Issue |
4.5% |
| Pruritus |
4.5% |
| Pulmonary Infarction |
4.5% |
| Respiratory Depression |
4.5% |
|
